Nessi Spacer
by Pharmacaribe
510(k) K091862
Active
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK091862 | Date20 Nov 2009 | StatusActive |
Official records
- FDA 510(k) database K091862
From the FDA record
- Received by the FDA
- 23 Jun 2009
- FDA decision
- 20 Nov 2009 (Substantially Equivalent)
- FDA review time
- 150 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- NVO
- Device class
- Class II
- Regulation
- 21 CFR Part 868.5630
- Advisory committee
- Anesthesiology
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Nessi Spacer is a medical delivery apparatus classified as a spacer for metered dose inhalers. It functions as a chamber positioned between the inhaler canister and the patient’s mouth, designed to slow and evaporate medication droplets. This reduces direct contact with the oropharynx, enhancing the deposition of medication in the lower respiratory tract. Its primary purpose aligns with the device type ‘Spacer, Direct Patient Interface’ as defined by regulatory nomenclature.
The Nessi Spacer is supplied as a single-use device and is intended for use in clinical settings, particularly within anesthesiology. It is not sterilised post-manufacture but is packaged in a manner suitable for direct patient use. The device is classified under FDA regulation number 868.5630 and holds a 510(k) clearance (K091862) for substantial equivalence. No additional regulatory markings or MRI safety classifications are specified in the available data.